These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24484760)

  • 1. Words of wisdom: Re: Punctuated evolution of prostate cancer genomes.
    Adler D; Offermann A; Perner S
    Eur Urol; 2014 Mar; 65(3):666-7. PubMed ID: 24484760
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromoplexy: a new category of complex rearrangements in the cancer genome.
    Shen MM
    Cancer Cell; 2013 May; 23(5):567-9. PubMed ID: 23680143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Punctuated evolution of prostate cancer genomes.
    Baca SC; Prandi D; Lawrence MS; Mosquera JM; Romanel A; Drier Y; Park K; Kitabayashi N; MacDonald TY; Ghandi M; Van Allen E; Kryukov GV; Sboner A; Theurillat JP; Soong TD; Nickerson E; Auclair D; Tewari A; Beltran H; Onofrio RC; Boysen G; Guiducci C; Barbieri CE; Cibulskis K; Sivachenko A; Carter SL; Saksena G; Voet D; Ramos AH; Winckler W; Cipicchio M; Ardlie K; Kantoff PW; Berger MF; Gabriel SB; Golub TR; Meyerson M; Lander ES; Elemento O; Getz G; Demichelis F; Rubin MA; Garraway LA
    Cell; 2013 Apr; 153(3):666-77. PubMed ID: 23622249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromoplexy: a new paradigm in genome remodeling and evolution.
    Wang K; Wang Y; Collins CC
    Asian J Androl; 2013 Nov; 15(6):711-2. PubMed ID: 23974363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer genomics: coming in waves.
    Seton-Rogers S
    Nat Rev Cancer; 2013 Jun; 13(6):379. PubMed ID: 23702923
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrative analysis of genomic aberrations associated with prostate cancer progression.
    Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic factors underlying prostate cancer.
    Luo JH; Yu YP
    Expert Rev Mol Med; 2003 Apr; 5(12):1-26. PubMed ID: 14585168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostate cancer: cytogenetic and molecular biology principles].
    Strohmeyer T; Effert P
    Med Klin (Munich); 1993 Aug; 88(8):482-4. PubMed ID: 8413050
    [No Abstract]   [Full Text] [Related]  

  • 9. The genomic complexity of primary human prostate cancer.
    Berger MF; Lawrence MS; Demichelis F; Drier Y; Cibulskis K; Sivachenko AY; Sboner A; Esgueva R; Pflueger D; Sougnez C; Onofrio R; Carter SL; Park K; Habegger L; Ambrogio L; Fennell T; Parkin M; Saksena G; Voet D; Ramos AH; Pugh TJ; Wilkinson J; Fisher S; Winckler W; Mahan S; Ardlie K; Baldwin J; Simons JW; Kitabayashi N; MacDonald TY; Kantoff PW; Chin L; Gabriel SB; Gerstein MB; Golub TR; Meyerson M; Tewari A; Lander ES; Getz G; Rubin MA; Garraway LA
    Nature; 2011 Feb; 470(7333):214-20. PubMed ID: 21307934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientific background of hormonal treatment of prostate cancer.
    Klijn JG
    Prog Clin Biol Res; 1990; 357():7-22. PubMed ID: 2217480
    [No Abstract]   [Full Text] [Related]  

  • 11. Words of wisdom. Re: Tracking the clonal origin of lethal prostate cancer.
    Passoni NM; Polascik TJ
    Eur Urol; 2014 Aug; 66(2):390-1. PubMed ID: 25305788
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostate cancer and epigenetics].
    Yamashita S
    Nihon Rinsho; 2016 May; 74 Suppl 3():75-9. PubMed ID: 27344707
    [No Abstract]   [Full Text] [Related]  

  • 14. [The future has already begun. Molecular oncology of prostatic carcinoma].
    Gschwend JE; Noldus J
    Urologe A; 2004 Jun; 43(6):645. PubMed ID: 15098091
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular biology of prostate carcinoma].
    Urologe A; 1997 May; 36(3 Suppl Molekular):1-8. PubMed ID: 9304276
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward an understanding of the molecular genetics of prostate cancer progression.
    Lijovic M; Frauman AG
    J Environ Pathol Toxicol Oncol; 2003; 22(1):1-15. PubMed ID: 12678401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic changes in prostatic carcinoma].
    Sauter G; Bubendorf L; Moch H; Gasser TC; Mihatsch MJ
    Pathologe; 1998 Jan; 19(1):63-8. PubMed ID: 9541944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathology of prostate cancer.
    Hughes C; Murphy A; Martin C; Sheils O; O'Leary J
    J Clin Pathol; 2005 Jul; 58(7):673-84. PubMed ID: 15976331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization.
    Joos S; Bergerheim US; Pan Y; Matsuyama H; Bentz M; du Manoir S; Lichter P
    Genes Chromosomes Cancer; 1995 Dec; 14(4):267-76. PubMed ID: 8605115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.
    Bianchi-Frias D; Basom R; Delrow JJ; Coleman IM; Dakhova O; Qu X; Fang M; Franco OE; Ericson NG; Bielas JH; Hayward SW; True L; Morrissey C; Brown L; Bhowmick NA; Rowley D; Ittmann M; Nelson PS
    Mol Cancer Res; 2016 Apr; 14(4):374-84. PubMed ID: 26753621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.